-
1
-
-
53749104092
-
Clinical application of intensity-modulated radiotherapy for head and neck cancer
-
Ballivy O, et al (2008) Clinical application of intensity-modulated radiotherapy for head and neck cancer. Clin Transl Oncol 10: 407-414.
-
(2008)
Clin Transl Oncol
, vol.10
, pp. 407-414
-
-
Ballivy, O.1
-
2
-
-
43049179752
-
Advances in radiation therapy of head and neck cancer
-
Popovtzer A and Eisbruch A (2008) Advances in radiation therapy of head and neck cancer. Expert Rev Anticancer Ther 8: 633-644.
-
(2008)
Expert Rev Anticancer Ther
, vol.8
, pp. 633-644
-
-
Popovtzer, A.1
Eisbruch, A.2
-
3
-
-
3042701812
-
Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma
-
Denis F, et al (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22: 69-76.
-
(2004)
J Clin Oncol
, vol.22
, pp. 69-76
-
-
Denis, F.1
-
4
-
-
34548428839
-
Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): An update
-
Pignon JP, le Maître A and Bourhis J (2007) Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69: 1544-1552.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.69
, pp. 1544-1552
-
-
Pignon, J.P.1
le Maître, A.2
Bourhis, J.3
-
5
-
-
47149113166
-
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: A phase II trial of the radiation therapy oncology group (RTOG 99-14)
-
Garden AS, et al (2008) Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys 71: 1351-1355.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 1351-1355
-
-
Garden, A.S.1
-
6
-
-
49049115379
-
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis
-
Machtay M, et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26: 3582-3589.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3582-3589
-
-
Machtay, M.1
-
7
-
-
0022550102
-
Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for esophageal cancer in Northern China: Endogenous formation of nitrosoproline and its inhibition by vitamin C
-
Lu SH, et al (1986) Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for esophageal cancer in Northern China: endogenous formation of nitrosoproline and its inhibition by vitamin C. Cancer Res 46: 1485-1491.
-
(1986)
Cancer Res
, vol.46
, pp. 1485-1491
-
-
Lu, S.H.1
-
8
-
-
0027195067
-
Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines
-
Leung PY, et al (1993) Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res 13: 475-480.
-
(1993)
Anticancer Res
, vol.13
, pp. 475-480
-
-
Leung, P.Y.1
-
9
-
-
0030939469
-
Effect of ascorbate oxidase on radical intensity and cytotoxic activity of ascorbate
-
Sakagami H and Satoh K (1997) Effect of ascorbate oxidase on radical intensity and cytotoxic activity of ascorbate. Anticancer Res 17: 1163-1166.
-
(1997)
Anticancer Res
, vol.17
, pp. 1163-1166
-
-
Sakagami, H.1
Satoh, K.2
-
10
-
-
33645555541
-
Intravenously administered vitamin C as cancer therapy: Three cases
-
Padayatty SJ, et al (2006) Intravenously administered vitamin C as cancer therapy: three cases. CMAJ 174: 937-942.
-
(2006)
CMAJ
, vol.174
, pp. 937-942
-
-
Padayatty, S.J.1
-
11
-
-
77955349971
-
Vitamin C: Intravenous use by supplementary and alternative medicine practitioners and adverse effects
-
Padaytty SJ, et al (2010) Vitamin C: Intravenous use by supplementary and alternative medicine practitioners and adverse effects. PLoS One 5: e11414.
-
(2010)
PLoS One
, vol.5
-
-
Padaytty, S.J.1
-
12
-
-
79953154942
-
Ascorbic acid and cancer: A review
-
Cameron E and Pauling L (1987) Ascorbic acid and cancer: a review. Proc Natl Acad Sci USA 75:4538-3542.
-
(1987)
Proc Natl Acad Sci USA
, vol.75
, pp. 4538-3542
-
-
Cameron, E.1
Pauling, L.2
-
13
-
-
0018669229
-
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial
-
Creagan ET, et al (1979) Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 301: 687-690.
-
(1979)
N Engl J Med
, vol.301
, pp. 687-690
-
-
Creagan, E.T.1
-
14
-
-
70349956364
-
Pharmacokinetics of vitamin C: Insights into the oral and intravenous administration of ascorbate
-
Duconge J, et al (2008) Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J 27: 7-19.
-
(2008)
P R Health Sci J
, vol.27
, pp. 7-19
-
-
Duconge, J.1
-
15
-
-
54949089044
-
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
-
Hoffer LJ, et al (2008) Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol 19: 1969-1974.
-
(2008)
Ann Oncol
, vol.19
, pp. 1969-1974
-
-
Hoffer, L.J.1
-
16
-
-
35248898320
-
Evidence-based radiation oncology in head and neck squamous cell carcinoma
-
Corvo R (2007) Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 85: 156-170.
-
(2007)
Radiother Oncol
, vol.85
, pp. 156-170
-
-
Corvo, R.1
-
17
-
-
47149113166
-
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: A phase II trial of the radiation therapy oncology group (RTOG 99-14)
-
Fei P and El-Deiry WS (2008) Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys 71: 1351-1355.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 1351-1355
-
-
Fei, P.1
El-Deiry, W.S.2
-
18
-
-
39749140207
-
Apoptosis preferentially eliminates irradiated g0 human lymphocytes bearing dicentric chromosomes
-
Belloni P, et al (2008) Apoptosis preferentially eliminates irradiated g0 human lymphocytes bearing dicentric chromosomes. Radiat Res 169: 181-187.
-
(2008)
Radiat Res
, vol.169
, pp. 181-187
-
-
Belloni, P.1
-
19
-
-
33847382879
-
Integrin-linked kinase interacts with caspase-9 and -8 in an adhesion-dependent manner for promoting radiation-induced apoptosis in human leukemia cells
-
Hess F, et al (2007) Integrin-linked kinase interacts with caspase-9 and -8 in an adhesion-dependent manner for promoting radiation-induced apoptosis in human leukemia cells. Oncogene 26: 1372-1384.
-
(2007)
Oncogene
, vol.26
, pp. 1372-1384
-
-
Hess, F.1
-
21
-
-
43449136770
-
Radiation enhances caspase 3 cleavage of Rad51 in BRCA2-defective cells
-
Brown ET, Robinson-Benion C and Holt JT (2008) Radiation enhances caspase 3 cleavage of Rad51 in BRCA2-defective cells. Radiat Res 169: 595-601.
-
(2008)
Radiat Res
, vol.169
, pp. 595-601
-
-
Brown, E.T.1
Robinson-Benion, C.2
Holt, J.T.3
-
22
-
-
0038301393
-
ESR spin trapping of hydroxyl radicals in aqueous solution irradiated with high-LET carbon-ion beams
-
Moritake T, et al (2003) ESR spin trapping of hydroxyl radicals in aqueous solution irradiated with high-LET carbon-ion beams. Radiat Res 159: 670-675.
-
(2003)
Radiat Res
, vol.159
, pp. 670-675
-
-
Moritake, T.1
-
23
-
-
0033601746
-
Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
-
Slee EA, et al (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144: 281-292.
-
(1999)
J Cell Biol
, vol.144
, pp. 281-292
-
-
Slee, E.A.1
-
24
-
-
68349154339
-
Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival
-
Hughes MA, et al (2009) Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell 35: 265-279.
-
(2009)
Mol Cell
, vol.35
, pp. 265-279
-
-
Hughes, M.A.1
-
25
-
-
0033535350
-
Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis
-
Desagher S, et al (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144: 891-901.
-
(1999)
J Cell Biol
, vol.144
, pp. 891-901
-
-
Desagher, S.1
-
26
-
-
34948846604
-
Bid is not required for Bax translocation during UV-induced apoptosis
-
Wu Y, et al (2007) Bid is not required for Bax translocation during UV-induced apoptosis. Cell Signal 19: 2468-2478.
-
(2007)
Cell Signal
, vol.19
, pp. 2468-2478
-
-
Wu, Y.1
-
27
-
-
34547429599
-
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo
-
Chen Q, et al (2005) Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 104: 8749-8754.
-
(2005)
Proc Natl Acad Sci USA
, vol.104
, pp. 8749-8754
-
-
Chen, Q.1
|